Investor List:

Top BioTech Series B Investors in New York City (150)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top BioTech investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Hiro Nozawa, Managing Director at Asahi Media Lab Ventures
Hiro Nozawa
Asahi Media Lab Ventures·Managing Director
Sweet spot: $250K
Range: $10K - $1M
Investors in San Francisco (CA), Investors in New York (NY)
Investors in AR/VR (Series B), Investors in Analytics (Series B), Investors in AR/VR (Series A), Investors in AR/VR (Seed), Investors in Analytics (Series A), Investors in Security (Seed), Investors in Gaming/eSports (Seed), Investors in Entertainment & Sports (Seed), Investors in BioTech (Series B), Investors in Entertainment & Sports (Series B), Investors in Analytics (Seed), Investors in Entertainment & Sports (Series A), Investors in Media/Content (Seed), Investors in IoT (Seed), Investors in Gaming/eSports (Series B), Investors in Gaming/eSports (Series A), Investors in IoT (Series B), Investors in Media/Content (Series B), Investors in BioTech (Seed), Investors in Security (Series B), Investors in IoT (Series A), Investors in Media/Content (Series A), Investors in Security (Series A), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Analytics (Seed), Investors in Analytics (Seed), Investors in AR/VR (Seed), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in Entertainment & Sports (Seed), Investors in FinTech (Seed), Investors in New York City (Other Lists), Investors in Entertainment & Sports (Seed), Investors in Gaming/eSports (Seed), Investors in IoT (Seed), Investors in Gaming/eSports (Seed), Investors in Media/Content (Seed), Investors in Media/Content (Seed), Investors in IoT (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Security (Seed), Investors in Analytics (Series A), Investors in Analytics (Series A), Investors in AR/VR (Series A), Investors in AR/VR (Series A), Investors in BioTech (Series A), Investors in Security (Seed), Investors in BioTech (Series A), Investors in Entertainment & Sports (Series A), Investors in Entertainment & Sports (Series A), Investors in Media/Content (Series A), Investors in IoT (Series A), Investors in FinTech (Series A), Investors in Gaming/eSports (Series A), Investors in FinTech (Series A), Investors in Gaming/eSports (Series A), Investors in IoT (Series A), Investors in Media/Content (Series A), Investors in Security (Series A), Investors in Analytics (Series B), Investors in AR/VR (Series B), Investors in FinTech (Series B), Investors in Entertainment & Sports (Series B), Investors in BioTech (Series B), Investors in Entertainment & Sports (Series B), Investors in Security (Series A), Investors in FinTech (Series B), Investors in Analytics (Series B), Investors in AR/VR (Series B), Investors in BioTech (Series B), Investors in Gaming/eSports (Series B), Investors in IoT (Series B), Investors in IoT (Series B), Investors in Gaming/eSports (Series B), Investors in Media/Content (Series B), Investors in Security (Series B), Investors in Media/Content (Series B), Investors in Security (Series B), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in AR/VR (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
EP
Emilie Poteat
Gaingels·Venture Partner
Sweet spot: $350K
Range: $200K - $500K
Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in New York (NY)
Investors in AI (Series B), Investors in BioTech (Series B), Investors in Education (Series B), Investors in Consumer Internet (Series B), Investors in Education (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in FinTech (Series B), Investors in AI (Seed), Investors in SaaS (Series B), Investors in AI (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Seed), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Education (Seed), Investors in Education (Seed), Investors in FinTech (Seed), Investors in Education (Seed), Investors in FinTech (Seed), Investors in New York City (Other Lists), Investors in FinTech (Seed), Investors in Consumer Internet (Seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in SaaS (Seed), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in Education (Series B), Investors in FinTech (Series B), Investors in BioTech (Series B), Investors in Education (Series B), Investors in Consumer Internet (Series B), Investors in FinTech (Series B), Investors in AI (Series B), Investors in FinTech (Series B), Investors in BioTech (Series B), Investors in Education (Series B), Investors in SaaS (Series B), Investors in SaaS (Series B), Investors in SaaS (Series B), Investors in AI (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed)
Photo of Lonne Jaffe, Managing Director at Insight Partners
Lonne Jaffe
Insight Partners·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Investors in Developer Tools (Series B), Investors in Developer Tools (Series A), Investors in Data Services (Series B), Investors in BioTech (Series B), Investors in Education (Series B), Investors in Education (Series A), Investors in Consumer Internet (Series B), Investors in Data Services (Series A), Investors in Enterprise (Series B), Investors in Security (Series B), Investors in Retail (Series A), Investors in Security (Series A), Investors in Retail (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Enterprise (Series A), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Developer Tools (Series A), Investors in Consumer Internet (Series A), Investors in Data Services (Series A), Investors in Education (Series A), Investors in Enterprise (Series A), Investors in Health IT (Series A), Investors in Retail (Series A), Investors in Health & Hospital Services (Series A), Investors in Security (Series A), Investors in Data Services (Series B), Investors in BioTech (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Developer Tools (Series B), Investors in Health IT (Series B), Investors in Education (Series B), Investors in Retail (Series B), Investors in Security (Series B), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series A), Investors in Health IT (Series B)
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Manufacturing (Series B), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Jonathan Mo, Principal at Alumni Ventures
Jonathan Mo
Alumni Ventures ·Principal
Sweet spot: $1M
Range: $50K - $5.0M
Investors in New York (NY)
Investors in Hardware (Seed), Investors in AI (Series B), Investors in Insurance (Seed), Investors in BioTech (Series B), Investors in EnergyTech (Series B), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in Hardware (Series B), Investors in Consumer Internet (Series B), Investors in Hardware (Series A), Investors in Insurance (Series B), Investors in BioTech (Seed), Investors in Insurance (Series A), Investors in Manufacturing (Series B), Investors in AI (Seed), Investors in Space (Series A), Investors in Space (Series B), Investors in Space (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in AI (Series A), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in EnergyTech (Seed), Investors in FinTech (Seed), Investors in Hardware (Seed), Investors in New York City (Other Lists), Investors in Consumer Internet (Seed), Investors in Insurance (Seed), Investors in Space (Seed), Investors in Manufacturing (Seed), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Consumer Internet (Series A), Investors in EnergyTech (Series A), Investors in Hardware (Series A), Investors in FinTech (Series A), Investors in Insurance (Series A), Investors in Manufacturing (Series A), Investors in Space (Series A), Investors in AI (Series B), Investors in FinTech (Series B), Investors in BioTech (Series B), Investors in EnergyTech (Series B), Investors in Consumer Internet (Series B), Investors in Hardware (Series B), Investors in Insurance (Series B), Investors in Space (Series B), Investors in Manufacturing (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in Consumer Internet (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
Photo of Florence Evina- Ze, Vice President at Bain Capital
Florence Evina- Ze
Bain Capital·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in Web3/Crypto (Series B), Investors in Insurance (Seed), Investors in BioTech (Series B), Investors in E-commerce (Series B), Investors in Real Estate/PropTech (Seed), Investors in E-commerce (Series A), Investors in Insurance (Series B), Investors in Enterprise (Series B), Investors in BioTech (Seed), Investors in Real Estate/PropTech (Series A), Investors in Real Estate/PropTech (Series B), Investors in Insurance (Series A), Investors in Web3/Crypto (Series A), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Web3/Crypto (Seed), Investors in E-commerce (Seed), Investors in BioTech (Seed), Investors in Web3/Crypto (Seed), Investors in E-commerce (Seed), Investors in Enterprise (Series A), Investors in FinTech (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Insurance (Seed), Investors in Health & Hospital Services (Seed), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Series A), Investors in E-commerce (Series A), Investors in Web3/Crypto (Series A), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in Insurance (Series A), Investors in Health & Hospital Services (Series A), Investors in Real Estate/PropTech (Series A), Investors in Web3/Crypto (Series B), Investors in FinTech (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B), Investors in E-commerce (Series B), Investors in Insurance (Series B), Investors in Real Estate/PropTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Seed), Investors in Enterprise Applications (Series A), Investors in Enterprise Applications (Series B), Investors in Health IT (Seed), Investors in Enterprise (Seed), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Health IT (Series B), Investors in FinTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Enterprise (Seed)
Photo of Daisy Wolf, Partner at Andreessen Horowitz
Daisy Wolf
Sweet spot: $20.0M
Range: $500K - $40.0M
Investors in New York (NY)
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in FinTech (Series B), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in FinTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in FinTech (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Health IT (Series B), Investors in FinTech (Seed)
Photo of Morgan Cheatham, Vice President at Bessemer Venture Partners
Morgan Cheatham
Sweet spot: $25.0M
Range: $1M - $250.0M
Investors in New York (NY)
Investors in AI (Series B), Investors in BioTech (Series B), Investors in Marketplaces (Series B), Investors in Enterprise (Series B), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Marketplaces (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series B), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Enterprise (Series A), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Marketplaces (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Enterprise (Series A), Investors in Health IT (Series A), Investors in Marketplaces (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Enterprise (Series B), Investors in Health IT (Series B), Investors in Marketplaces (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Enterprise (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Marketplaces (Seed), Investors in Enterprise (Seed)